Key facts
- This page summarizes William A. Hagstrom's Form 4 filing for CareDx, Inc. (CDNA).
- 5 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 13 Jun 2025, 17:06.
William A. Hagstrom - 11 Jun 2025 Form 4 Insider Report for CareDx, Inc. (CDNA)
- Reporting relationship
- Director
- Issuer ticker
- CDNA
- Reported as of
- 11 Jun 2025
- Net transaction value
- -$129,865
- SEC form
- 4
- Accepted by SEC
- 13 Jun 2025, 17:06:22 UTC
- Prior SEC filing
- 30 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ William A. Hagstrom
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
William A. Hagstrom filed Form 4 for CareDx, Inc. (CDNA) on 13 Jun 2025.
Change
- Previous filing in this sequence was filed on 30 May 2025.
- Current net transaction value: -$129,865.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001042875
Primary reporting owner
HAGSTROM WILLIAM A
- Relationship
- Director
- Address
- C/O CAREDX, INC., 8000 MARINA BOULEVARD, BRISBANE
- Signature
- /s/ William A. Hagstrom
- Signature date
- 13 Jun 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CDNA
transaction
Common Stock
Options Exercise
- Transaction value
- $221,100
- Shares
- +15,000
- Change %
- +28%
- Price
- $14.74
- Shares after
- 68,979
- Date
- 11 Jun 2025
- Ownership
- Direct
CDNA
transaction
Common Stock
Options Exercise
- Transaction value
- $34,952
- Shares
- +4,391
- Change %
- +6.4%
- Price
- $7.96
- Shares after
- 73,370
- Date
- 11 Jun 2025
- Ownership
- Direct
CDNA
transaction
Common Stock
Sale
- Transaction value
- $385,918
- Shares
- -19,391
- Change %
- -26%
- Price
- $19.90
- Shares after
- 53,979
- Date
- 11 Jun 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CDNA
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -15,000
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 11 Jun 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,000
- Exercise price
- $14.74
- Footnotes
- F2
CDNA
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -4,391
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 11 Jun 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,391
- Exercise price
- $7.96
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.69 to $20.20, inclusive. The reporting person undertakes to provide to CareDx, Inc., any security holder of CareDx, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
Footnote F2
The shares subject to this option vested fully on June 20, 2019.
Footnote F3
The shares subject to this option vested fully on June 16, 2024.